Abstract
New biological treatments are being developed at a record place, but their
potential could be compromised by a significant obstacle: the delivery of
these drugs into the body.
Pharmaceutical delivery is now nearly as important as product. New systems are
being developed, and Kalorama' s Drug Delivery Markets Series covers these new
systems.
The fourth volume of this series, Kalorama' s Drug Delivery Markets, Vol. IV:
Transdermal and Transmucosal Drug Delivery is a complete overview of a
delivery mechanism that offers some advantages: low pain, infection risk,
fewer side effects and polonged delivery over time.
Transdermal delivery has the advantage of being able deliver drugs over a long
period of time, deliver a substantial amount and do so in a way that causes no
pain or discomfort to the patient.
Nicotine patches have lead the growth in this delivery area, and patches are
the product most commonly associated with this area, but transdermal delivery
includes new transmission methods such as electrotransfer and iontophoresis.
Kalorama' s Drug Delivery Markets, Vol. IV: Transdermal and Transmucosal Drug
Delivery covers the entire market of drugs delivered through the skin or
muocus membrane, as well as the delivery technologies. The
transdermal/transmucosal drug delivery market is expected to grow steadily
with biotechnology drugs that require novel delivery technologies leading this
growth. The volume features
- Complete Round-Up of Key Companies
- Current Market Size for transdermal and transmucosal segments, as
well as the pharmaceutical and technology-only segments
- Forecasts to 2011 for Strategic Business Planning
- Complete Discussion of Delivery Technologies and how they operate.
- Review of Future Products
Market coverage includes both the pharmaceutical products that utilize the
drug delivery technology. The second section encompasses drug delivery
technology and the revenues earned from licensing that technology. Because
drug delivery technology is an integral part of sales of pharmaceuticals and
drug delivery technology cannot exist without pharmaceuticals, revenues have
been reported that include pharmaceutical sales for products utilizing that
technology.
This market is expected to increase substantially within the forecast period.
Additionally, a growing focus on ease of delivery to assist in patient
compliance could help drive demand for both transdermal and transmucosal
delivery systems.
View Cart
